Normal Blood Cell Morphology on Peripheral Smear | Neutrophils, Lymphocytes, Eosinophils & More | Hematopathology Education

Anisocytosis and poikilocytosis are morphological abnormalities: (1) Anisocytosis: variation in red blood cell size, quantified by RDW (reference <15%); (2) Poikilocytosis: variation in red blood cell shape, including spherocytes, elliptocytes, and schistocytes. Hypochromia and anisocromia are morphological abnormalities: (1) Hypochromia: decreased hemoglobin content in red blood cells, confirmed by decreased MCHC; (2) Anisocromia: variation in hemoglobin coloration, indicating abnormal hemoglobin synthesis.

Anisocytosis refers to variation in erythrocyte size, while poikilocytosis refers to variation in shape. Normal erythrocytes are biconcave discs without nuclei. Common abnormal shapes include spherocytes, elliptocytes, schistocytes, and sickle cells. The RDW coefficient (normal 11.5-15.1%) indicates population heterogeneity. A bimodal RDW distribution suggests two erythrocyte populations. These morphological findings guide diagnosis: spherocytes suggest hereditary spherocytosis or autoimmune hemolytic anemia; schistocytes suggest microangiopathic hemolytic anemia; sickle cells suggest sickle cell disease.

Erythrocyte morphological alterations have diagnostic significance: schistocytes indicate microangiopathic hemolytic anemia; megalocytes with Cabot rings/Howell-Jolly bodies indicate megaloblastic anemia; dacrocytes indicate myelofibrosis; microspherocytes indicate hereditary spherocytosis; acanthocytes indicate liver disease; codocytes indicate thalassemia or liver disease; elliptocytes indicate iron deficiency or thalassemia; ovalocytes indicate megaloblastic anemia. Anisocytosis (size variation) is quantified by MCV; poikilocytosis (shape variation) is qualitatively assessed. These findings guide differential diagnosis and treatment decisions.

Abnormal erythrocyte shapes include: spherocytes (spherical, no central pallor, hereditary spherocytosis, burns, hemolytic anemia), elliptocytes (oval/pencil-shaped, potassium-related), target cells (target-like appearance, thalassemia, liver disease, splenectomy), stomatocytes (stoma-shaped, hereditary stomatocytosis), schistocytes (fragmented, helmet/triangle-shaped, hemolytic disorders), acanthocytes (long sharp projections, acanthocytosis), echinocytes (short blunt projections, echinocytosis), and teardrop cells (lachrymocytes, myelofibrosis, sickle cell disease). Poikilocytosis refers to variation in shape, while anisocytosis refers to variation in size.

Red blood cell morphology reveals anemia type: Anisocytosis (size variation) measured by RDW. Poikilocytosis (shape variation) includes target cells (thalassemia, liver disease), sickle cells (sickle cell disease), schistocytes (microangiopathic hemolysis), spur cells (liver disease), and acanthocytes (abetalipoproteinemia). Howell-Jolly bodies indicate splenic dysfunction. These morphological findings guide diagnosis.

Normal platelets measure 1-3 micrometers with 5-6% potentially reaching 4-5 micrometers. Under Romanowsky staining, they display a central chromomere (alpha granules for adhesion/activation) and peripheral hyaloplasm. Normal platelet count ranges from 140-400 × 10^9/L. Platelet clumping is an in vitro EDTA-induced phenomenon causing falsely reduced counts through glycoprotein IIb/IIIa receptor activation. Large platelets (>5 micrometers) and giant platelets (≥7 micrometers) frequently escape automated detection, requiring manual platelet estimation. MYH9 disorders (May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome) represent a spectrum of conditions caused by myosin heavy chain 9 mutations, characterized by macrothrombocytopenia with large/giant platelets and Dohle-like inclusions in neutrophils. Bernard-Soulier syndrome results from glycoprotein Ib-IX-V complex mutations, causing large platelets with normal function. Understanding these fundamentals enables recognition of morphological abnormalities and prevents misreported platelet counts.

Platelet evaluation includes quantitative assessment (platelet count, normal range 150,000-400,000) and qualitative assessment (bleeding time, platelet aggregation). Peripheral smear allows manual counting and morphological assessment, particularly valuable in thrombocytopenia with large proplatelets. Function testing evaluates platelet plug formation capacity, altered in qualitative disorders and conditions like Bernard-Soulier syndrome.

Manual platelet counting involves using a Neubauer chamber with ammonium oxalate diluent to count platelets in specific grid areas, while extended blood smear examination allows visualization of platelet morphology and identification of artifacts like giant platelets, clumps, or satellitism that can cause pseudothrombocytopenia; the manual method has a 10-25% variation margin compared to automated impedance methods with less than 3% variation, and according to ICLH guidelines, impedance-based automated counting with flow cytometry is the reference method, though manual verification of extended smears remains essential for detecting morphological abnormalities that affect counting accuracy.

Platelet abnormalities include giant platelets (seen in Bernard-Soulier syndrome and Wiskott-Aldrich syndrome), small platelets (associated with reactive thrombocytosis), and platelet clumps (may indicate EDTA-dependent pseudothrombocytopenia). Giant platelets are larger than normal and often accompany qualitative platelet function defects. Small platelets may be seen in conditions with increased platelet production. Platelet clumps can artifactually reduce platelet counts and require careful interpretation.

Platelet abnormalities affecting primary hemostasis can be quantitative (thrombocytopenia - low platelet count) or qualitative (platelet function defects). Quantitative defects involve reduced platelet production or increased destruction/consumption. Qualitative defects involve problems with platelet adhesion, activation, granule release, or aggregation despite normal platelet numbers.

Peripheral blood smear examination provides crucial diagnostic information. In acute leukemia, you may see blasts (immature cells) and a 'leukemic hiatus' (absence of intermediate maturation stages). A blast percentage >20% in peripheral blood is diagnostic of acute leukemia. In chronic leukemia, you may see mature clonal cells. The presence of basophilic stippling (aggregates of myeloperoxidase enzyme) suggests acute promyelocytic leukemia.

Peripheral blood smear analysis provides critical diagnostic information: (1) Hypersegmented neutrophils (6-10 lobes) indicate megaloblastic anemia from B12/folate deficiency, (2) Dysplastic changes suggest myelodysplastic syndrome, (3) Fragmentocytes suggest thrombotic microangiopathies (TTP, HUS), (4) Blast cells indicate leukemia, (5) Spherocytes suggest hereditary spherocytosis, (6) Schistocytes suggest microangiopathic hemolytic anemia. The absence of fragmentocytes makes TTP unlikely. Hypersegmented neutrophils are a key indicator for megaloblastic anemia requiring B12/folate supplementation.

A peripheral blood smear examination reveals key morphological abnormalities that help diagnose anemia etiology: hypochromia indicates decreased hemoglobin (commonly iron deficiency); megaloblastic anemia shows hypersegmented neutrophils (6+ lobes) due to DNA synthesis defects from B12/folate deficiency; schistocytes indicate microangiopathic hemolytic anemia; microspherocytes suggest autoimmune hemolytic anemia or hereditary spherocytosis; sickle cells point to sickle cell disease; target cells appear in sickle cell disease and thalassemia; bite cells indicate G6PD deficiency or thalassemia; basophilic stippling suggests thalassemia, alcohol abuse, or heavy-metal poisoning; and ring sideroblasts (seen on bone marrow aspirate) indicate iron overload, myelodysplastic syndromes, or certain congenital disorders.

The peripheral blood smear is a fundamental hematological study that analyzes two key cellular populations: the white blood cell differential and red blood cell morphology. White blood cell differential includes left shift (immature neutrophils, indicating bacterial infection, trauma, or hemorrhage) and right shift (lymphocytic predominance, suggesting viral infection). Red blood cell morphology reveals various pathological forms: spherocytes (hereditary spherocytosis, immune hemolytic anemias), stomatocytes (hereditary stomatocytosis, hepatic cirrhosis), schistocytes (microangiopathic hemolytic anemias like HELLP syndrome), echinocytes (renal failure, metabolic disorders), acanthocytes (abetalipoproteinemia, alcoholic liver disease), drepanocytes (sickle cell anemia), teardrop cells (myelodysplastic syndromes), target cells (thalassemia), and rouleaux formation (multiple myeloma). Inclusions include Howell-Jolly bodies (asplenia, megaloblastic anemia) and Heinz bodies (hemoglobinopathies, G6PD deficiency).

Leukemia diagnosis relies on peripheral smear appearance and immunophenotyping. CLL shows conventional lymphocyte appearance (lymphocytes equal to RBC size) with smudge cells. CML shows garden party appearance with heterogeneous cell types. AML shows diffuse positivity on immunophenotyping. ALL shows dot and block positivity. Auer rods are seen in AML M1-M4 subtypes. These features are essential for differential diagnosis and classification.

In Hematology Flow laboratories, 75% of normal samples are auto-validated. For the 25% showing leukocyte pathology, flow cytometry replaces manual microscopy. For 80% of pathological samples, results are auto-validated after CytoDiff analysis. The CytoDiff reagent contains six monoclonal antibodies: CD16 (eosinophils, basophils, activated T-cells), CD19 (B-cells), CD34 (blasts), CD45 (pan-leukocyte), CD11c (monocytes), and CD16 (neutrophils, pro-inflammatory monocytes). Analysis follows hierarchical gating from obvious to complex populations.

Hematology analyzers use impedance, light scattering, or fluorescence technologies. Impedance measures cell size by electrical resistance changes. Light scattering provides detailed cell characteristics. Flow cytometry uses fluorescent markers that emit light when excited by lasers. Different wavelengths (UV, visible, infrared) enable multi-parameter analysis. Sample collection requires specific anticoagulants: blood in EDTA tubes, body fluids in heparin, tissue samples in saline. Bone marrow aspiration is performed at the posterior superior iliac spine. Samples are processed for hemograms, iron studies (Prussian blue staining), and cell morphology. Iron studies assess iron stores using Prussian blue staining. Cideroblasts indicate iron availability. These findings guide diagnosis of iron deficiency and other hematological conditions.

Automated staining systems offer significant advantages over manual methods for blood smear and bone marrow preparation, including standardized, consistent results, reduced turnaround time, elimination of reagent wastage and cross-contamination, and improved morphological visualization of cellular details such as nucleoli and granules, which is particularly valuable for diagnosing complex hematological conditions like myelodysplastic syndromes and leukemias; however, successful implementation requires proper quality control measures including daily buffer pH checks and technician involvement in customizing staining programs to suit specific laboratory needs and clinical requirements.

Bone marrow aspiration is performed at the posterior superior iliac spine after cleaning and local anesthesia. The needle is inserted slowly until fixation, then aspiration is performed to obtain hematopoietic tissue. Microscopic examination reveals increased cellularity with monotonous blast populations. Flow cytometry determines immunophenotype to classify leukemia as myeloid or lymphoblastic, as each requires specific treatment. Cytogenetic and molecular tests follow for prognosis determination. The complete diagnostic workflow includes clinical history, hemogram evaluation, peripheral smear, bone marrow aspiration, flow cytometry, and molecular testing to establish diagnosis, classify subtype, and guide treatment decisions.

Automated hematology analyzers use flow cytometry with fluorescence to classify leukocytes based on size, internal complexity, and surface markers. The system compares cell characteristics against reference distributions, generating automated differentials when populations are clearly distinct. When abnormalities are detected—such as homogeneous lymphocytes in infectious mononucleosis, blasts in acute leukemia, or atypical lymphocytes in mantle cell lymphoma—the system triggers alarms requiring manual blood smear examination. This technology enables rapid initial assessment but requires human verification for complex cases.